Applications of Gold Nanoparticles in Brain Diseases across the Blood-Brain Barrier

被引:3
|
作者
Zhang, Jun [1 ]
Yang, Ting [1 ]
Huang, Wan [1 ]
Yu, Yao [1 ]
Sun, Taolei [1 ]
机构
[1] Wuhan Univ Technol, Sch Chem Chem Engn & Life Sci, Wuhan 430070, Peoples R China
基金
中国国家自然科学基金;
关键词
Blood-brain barrier; gold nanoparticles; brain diseases; drug delivery; Alzheimer's disease; brain tumors; BETA-AMYLOID PEPTIDES; DRUG-DELIVERY; TRANSFERRIN RECEPTOR; TARGETED NANOPARTICLES; FOCUSED ULTRASOUND; PARTICLE-SIZE; CNS DELIVERY; BIODISTRIBUTION; DOXORUBICIN; CROSS;
D O I
10.2174/0929867329666220527121943
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Brain diseases, including Alzheimer's disease (AD), brain tumors and Parkinson's disease (PD), pose heavy pressure on the public healthcare system. The main obstacle to vanquish brain diseases is the blood-brain barrier (BBB), which is a selective barrier mainly formed by brain endothelial cells. BBB prevents almost all drugs from reaching the brain, thereby hindering drug delivery. Over the past few decades, considerable signs of progress have been made in crossing the BBB and treating brain diseases. Gold nanoparticles (AuNPs) demonstrate the characteristics of adjustable size, unique optical properties, flexible surface modification, and good biocompatibility, which all contribute AuNPs as a promising candidate in biomedical fields. This article reviews the structure and properties of BBB, and discusses main transport routes through the BBB. Besides, nanoparticles, specially AuNPs applied in brain diseases as main drug delivery platforms, are systematically summarized, emphasizing several methods to modify AuNPs, including tuning particle size and surface modification, which are aimed at promoting BBB penetration or prolonging circulation time of AuNPs. In addition, AuNPs utilized in brain diseases are introduced in detail from the aspects of brain imaging, AD, brain tumors, and PD. Prospects and challenges that need to be considered in further investigations and clinical transformation of AuNPs used in brain diseases are also included, hoping to bring new insights into the applications of AuNPs in brain diseases.
引用
收藏
页码:6063 / 6083
页数:21
相关论文
共 50 条
  • [31] Pathogen translocation across the blood-brain barrier
    Pulzova, Lucia
    Bhide, Mangesh R.
    Andrej, Kovac
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2009, 57 (03): : 203 - 213
  • [32] Deltorphin transport across the blood-brain barrier
    Fiori, A
    Cardelli, P
    Negri, L
    Savi, MR
    Strom, R
    Erspamer, V
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (17) : 9469 - 9474
  • [33] Drug transport across the blood-brain barrier
    Fricker, G
    PHARMACOKINETIC CHALLENGES IN DRUG DISCOVERY, 2002, 37 : 139 - 154
  • [34] Drug transport across the blood-brain barrier
    Pardridge, William M.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2012, 32 (11): : 1959 - 1972
  • [35] The transport of manganese across the blood-brain barrier
    Aschner, M
    NEUROTOXICOLOGY, 2006, 27 (03) : 311 - 314
  • [36] REGULATION OF PERMEABILITY ACROSS THE BLOOD-BRAIN BARRIER
    Easton, Alexander S.
    BIOLOGY AND REGULATION OF BLOOD-TISSUE BARRIERS, 2013, 763 : 1 - 19
  • [37] Drug delivery across the blood-brain barrier
    Hartz, AMS
    Bauer, B
    Baehr, CH
    Miller, DS
    Fricker, G
    CURRENT NANOSCIENCE, 2005, 1 (03) : 203 - 209
  • [38] Microbubbles Deliver Across the Blood-Brain Barrier
    Ritter, Amy
    BIOPHARM INTERNATIONAL, 2011, 24 (11) : 10 - 10
  • [39] Charting the course across the blood-brain barrier
    Nathanson, David
    Mischel, Paul S.
    JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (01): : 31 - 33
  • [40] Passage of parasites across the blood-brain barrier
    Masocha, Willias
    Kristensson, Krister
    VIRULENCE, 2012, 3 (02) : 202 - 212